Johannes Ruige

Dipeptidyl Peptidase 4 Is a Novel Adipokine Potentially Linking Obesity to the Metabolic Syndrome

Daniela Lamers, Susanne Famulla, Nina Wronkowitz et al. · Diabetes · 2011 · 574 citations · Full text

Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (DEPICT-1): 24 week results from a multicentre, double-blind, phase 3, randomised controlled trial

Paresh Dandona, Chantal Mathieu, Moshe Phillip et al. · The Lancet Diabetes & Endocrinology · 2017 · 286 citations · Full text

Metabolic Syndrome, Type 1, Diabetes Management +9

Identification and Validation of Novel Adipokines Released from Primary Human Adipocytes

Stefan Lehr, Sonja Hartwig, Daniela Lamers et al. · Molecular & Cellular Proteomics · 2011 · 238 citations · Full text

Obesity, Metabolic Syndrome, Novel Adipokines +11

Secretory Products From Epicardial Adipose Tissue of Patients With Type 2 Diabetes Mellitus Induce Cardiomyocyte Dysfunction

Sabrina Greulich, Bujar Maxhera, Guy Vandenplas et al. · Circulation · 2012 · 197 citations · Full text

Performance of a predictive model to identify undiagnosed diabetes in a health care setting.

Caroline A. Baan, Johannes Ruige, Ronald P. Stolk et al. · Diabetes Care · 1999 · 185 citations